Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study

1. López González, A.
2. Del Barco Berrón, S.
3. Grau, I.
4. Galan, M.
5. Castelo Fernández, B.
6. Cortés, A.
7. Sánchez Rovira, P.
8. Martinez-Bueno, A.
9. Gonzalez, X.
10. García, A.
11. Gener, P.
12. Mina, L.
13. Alcalá-López, D.
14. Sampayo, M.
15. Cortés, J.
16. Pérez-Garcia, J.M.
17. Llombart-Cussac, A.
18. López-Miranda, E.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3390/CANCERS14235880 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus